Table 5.
Attitude towards ADR reporting among hospital pharmacists (n = 342)
| Attitude items | Level of agreement, n (%) | Median (IQR) scores | ||||
|---|---|---|---|---|---|---|
| Strongly Disagree (1) | Disagree (2) | Neutral (3) | Agree (4) | Strongly Agree (5) | ||
| 1. I am willing to spend enough time to discuss patient adverse drug reaction (ADR) on regular basis with my manager | 11 (3.2) | 5 (1.5) | 16 (4.7) | 198 (57.9) | 112 (32.7) | 4 (4–5) |
| 2. There should be an incentive for pharmacists who are reporting ADR | 19 (5.6) | 27 (7.9) | 58 (17) | 133 (38.9) | 105 (30.7) | 4 (3–5) |
| 3. Patient should NOT allow to report ADRa | 122 (35.7) | 169 (49.4) | 25 (7.3) | 18 (5.3) | 8 (2.3) | 2 (1–2) |
| 4. I believe that ADR reporting should be made mandatory for practicing pharmacists | 16 (4.7) | 20 (5.8) | 51 (14.9) | 144 (42.1) | 111 (32.5) | 4 (3–5) |
| 5. It is important to report ADRs in order to answer the questions that may arise in my practice | 5 (1.5) | 2 (0.6) | 35 (10.2) | 190 (55.6) | 110 (32.2) | 4 (4–5) |
| 6. Reporting of ADRs is important to show patients that their concerns are taken seriously | 9 (2.6) | 7 (2) | 34 (9.9) | 171 (50) | 121 (35.4) | 4 (4–5) |
IQR interquartile range
aScoring for item 3 is reversed, as the statement was negatively worded